Entity Common Stock, Shares Outstanding of Blueprint Medicines Corp from 10 Jun 2015 to 29 Apr 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Blueprint Medicines Corp quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 10 Jun 2015 to 29 Apr 2025.
  • Blueprint Medicines Corp Entity Common Stock, Shares Outstanding for the quarter ending 29 Apr 2025 was 64,582,163, a 3.1% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Blueprint Medicines Corp Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 64,582,163 +1,965,261 +3.1% 29 Apr 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 63,906,011 +2,673,714 +4.4% 11 Feb 2025 10-K 13 Feb 2025 2024 FY
Q3 2024 63,525,838 +2,736,126 +4.5% 28 Oct 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 63,345,465 +2,680,716 +4.4% 30 Jul 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 62,616,902 +2,149,557 +3.6% 30 Apr 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 61,232,297 +1,248,764 +2.1% 13 Feb 2024 10-K 15 Feb 2024 2023 FY
Q3 2023 60,789,712 +959,101 +1.6% 23 Oct 2023 10-Q 26 Oct 2023 2023 Q3
Q2 2023 60,664,749 +945,179 +1.6% 28 Jul 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 60,467,345 +896,798 +1.5% 28 Apr 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 59,983,533 +780,533 +1.3% 14 Feb 2023 10-K 16 Feb 2023 2022 FY
Q3 2022 59,830,611 +992,577 +1.7% 28 Oct 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 59,719,570 +1,145,539 +2% 29 Jul 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 59,570,547 +1,229,020 +2.1% 29 Apr 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 59,203,000 14 Feb 2022 10-K 17 Feb 2022 2021 FY
Q3 2021 58,838,034 +3,107,230 +5.6% 25 Oct 2021 10-Q 28 Oct 2021 2021 Q3
Q2 2021 58,574,031 +3,301,956 +6% 26 Jul 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 58,341,527 +4,151,563 +7.7% 26 Apr 2021 10-Q 29 Apr 2021 2021 Q1
Q3 2020 55,730,804 +6,528,682 +13% 26 Oct 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 55,272,075 +6,156,500 +13% 24 Jul 2020 10-Q 30 Jul 2020 2020 Q2
Q1 2020 54,189,964 +5,336,031 +11% 30 Apr 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 54,027,009 10 Feb 2020 10-K 13 Feb 2020 2019 FY
Q3 2019 49,202,122 +5,251,747 +12% 31 Oct 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 49,115,575 +5,227,843 +12% 26 Jul 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 48,853,933 +5,016,596 +11% 06 May 2019 10-Q 09 May 2019 2019 Q1
Q3 2018 43,950,375 +4,747,175 +12% 26 Oct 2018 10-Q 30 Oct 2018 2018 Q3
Q2 2018 43,887,732 +4,765,383 +12% 27 Jul 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 43,837,337 +4,818,945 +12% 30 Apr 2018 10-Q 02 May 2018 2018 Q1
Q3 2017 39,203,200 +11,876,008 +43% 25 Oct 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 39,122,349 +11,840,599 +43% 31 Jul 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 39,018,392 +11,817,121 +43% 01 May 2017 10-Q 03 May 2017 2017 Q1
Q3 2016 27,327,192 +226,401 +0.84% 08 Nov 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 27,281,750 +170,348 +0.63% 08 Aug 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 27,201,271 29 Feb 2016 10-K 11 Mar 2016 2015 FY
Q3 2015 27,100,791 02 Nov 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 27,111,402 10 Jun 2015 10-Q 11 Jun 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.